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Although anaemia is recognised as a feature of colorectal cancer, the precise risk is unknown. We performed a case–control study
using electronic primary care records from the Health Improvement Network database, UK. A total of 6442 patients had a diagnosis
of colorectal cancer, and were matched to 45066 controls on age, sex, and practice. We calculated likelihood ratios and positive
predictive values for colorectal cancer in both sexes across 1gdl
 1 haemoglobin and 10-year age bands, and examined the features
of iron deficiency.In men, 178 (5.2%) of 3421 cases and 47 (0.2%) of 23928 controls had a haemoglobin o9.0gdl
 1, giving a
likelihood ratio (95% confidence interval) of 27 (19, 36). In women, the corresponding figures were 227 (7.5%) of 3021 cases and
58 (0.3%) of 21138 controls, a likelihood ratio of 41 (30, 61). Positive predictive values increased with age and for each 1gdl
 1
reduction in haemoglobin. The risk of cancer for current referral guidance was quantified. For men over 60 years with a haemoglobin
o11gdl
 1 and features of iron deficiency, the positive predictive value was 13.3% (9.7, 18) and for women with a haemoglobin
o10gdl
 1 and iron deficiency, the positive predictive value was 7.7% (5.7, 11). Current guidance for urgent investigation of anaemia
misses some patients with a moderate risk of cancer, particularly men.
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Iron-deficiency anaemia has long been recognised as a feature of
colorectal cancer (Goodman and Irvin, 1993). It is present in 11–
57% of cancers (Curless et al, 1994; Majumdar et al, 1999;
Roncoroni et al, 1999; Young et al, 2000) and is particularly
suggestive of caecal tumours (Dunne et al, 2002). Patients with
anaemia as their presenting feature of cancer have worse staging
(Gonzalez-Hermoso et al, 2004) and mortality (Stapley et al, 2006).
Thus, referral of patients with iron-deficiency anaemia for
investigation of possible gastrointestinal blood loss is recom-
mended. The main source of referral advice is the Referral
Guidelines for Suspected Cancer (NICE, 2005). These guidelines,
updated in 2005 and sent to all UK general practitioners, suggest
urgent referral for unexplained iron-deficiency anaemia, in a man
of any age with a haemoglobin o11gdl
 1, or a nonmenstruating
woman with a haemoglobin o10gdl
 1. Different advice comes
from the British Society of Gastroenterology (BSG) guidelines,
which suggests investigation of iron deficiency in men, and women
over 50 or postmenopausal, once the haemoglobin value is below
the laboratory’s quoted normal range, but without suggesting a
level of haemoglobin requiring urgent investigation (Goddard
et al, 2005).
There is very little research evidence to guide the choice of a
threshold haemoglobin warranting investigation. Only three
studies have estimated the risk of colorectal cancer posed
by iron-deficiency anaemia, and none for a specific threshold.
The first study examined 695 patients referred for investigation
under the BSG guidance and identified colorectal cancer in 6.3%.
Cancer was more common in men, those over 50, and in those with
a haemoglobin of 9.0gdl
 1 or below (James et al, 2005). The
second examined 431 patients with iron-deficiency anaemia
(haemoglobin below 12gdl
 1 in men and 11gdl
 1 in women,
with microcytosis) and 32 (7.4%) colorectal cancers were identified
(Logan et al, 2002). The degree of anaemia was not associated with
the likelihood of cancer (Yates et al, 2004). Finally, a smaller study
in a single general practice followed a cohort of 26 patients with
iron-deficiency anaemia for 5 years, with two colorectal cancers
being discovered (Stellon and Kenwright, 1997).
Less clear is the need for investigation of anaemia without iron
deficiency, or for iron deficiency without anaemia. In iron
deficiency without anaemia, two studies have estimated that the
risk of cancer is around five times the background risk (Ioannou
et al, 2002; Sawhney et al, 2007). Both these studies were based on
small numbers of cancers, and were of patients already selected for
investigation.
A third study examined the primary care records of 349
colorectal cancer patients and 1788 age- and sex-matched controls,
and calculated positive predictive values (PPVs) of 0.97% for
colorectal cancer for haemoglobin values in the range 10.0–
12.9gdl
 1 and 2.3% for values below 10gdl
 1, but did not
examine markers of iron deficiency (Hamilton et al, 2005).
Conversely, patients with anaemia and a ferritin above 100ngml
 1
have a risk of cancer little above those who are neither anaemic nor
iron-deficient (Sawhney et al, 2007).
In the general population, anaemia is more common with
increasing age. A large prevalence study was reported from the
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sUnited States in 2004, with anaemia defined as a haemoglobin
o13.0gdl
 1 in men and o12.0gdl
 1 in women (Guralnik et al,
2004). In the age group of 50–64 years, 4.4% of men and 6.6% of
women were anaemic; the percentage with anaemia increased
progressively with each age band up to 85þ years, when 26.1% of
men and 20.1% of women were anaemic.
The incidence of colorectal cancer also rises with age: annual
rates per 100000 in 50- to 54-year olds are 44.7 in men and 33.1 in
women; and 504 and 323, respectively, in those aged 85þ (Cancer
Research UK, 2003). As both anaemia prevalence and colorectal
cancer incidence rise with age, it is possible that the relative risk of
colorectal cancer with anaemia is largely independent of age; this is
a tacit assumption of current guidance. No study has been large
enough to calculate the risk of colorectal cancer with anaemia for
different ages, sexes, and haemoglobin values. This study aimed to
address this evidence gap.
METHODS
We studied data from The Health Improvement Network (THIN),
which uploads electronic medical records from GP practices
using the VISION computer system. The records contain patient
characteristics, all consultations, diagnoses, and primary care
investigations. The database has 2.2 million currently active
patients in over 300 practices; 4.7 million patients when historical
data are included. Laboratory results have been transmitted
electronically to most practices from the year 2000.
Identification of cases and controls
All patients with colorectal cancer were identified, who were aged
30 years or older, and diagnosed between January 2000 and July
2006. Up to seven controls were randomly selected for each case,
using a computerised random numbers sequence. Controls were
free from colorectal cancer and were matched for practice, sex, and
age. Where possible controls were born in the same year as cases,
if none were available within 1 year of the cases, the range was
expanded to 2 years, continuing to a maximum of 5 years. All
participants had at least 2 years of electronic records prior to the
date of diagnosis of the case (the index date). The above stages of
the data preparation were performed by THIN staff.
Haemoglobin results were taken in the year before the index
dates were studied. If more than one haemoglobin measurement
had been taken, the final value was used for analysis. Mean cell
volume (MCV) and ferritin results for the same year were also
collated. Microcytosis was defined as an MCV o80.0fl, and a low
ferritin as o20ngml
 1.
Analysis
Associations between anaemia, microcytosis, and low ferritin and
colorectal cancer were estimated using multivariable conditional
logistic regression. For the calculation of PPVs, haemoglobin
values were stratified into six bands: below 9.0 and 1gdl
 1 bands
thereafter, up to 13.0gdl
 1. Age was stratified into four bands:
30–59 (there were too few cancers in this band for meaningful
subdivision) and 10-year bands thereafter, up to 80þ years. The
sexes were analysed separately. For each age/haemoglobin/sex
triad, we calculated the positive likelihood ratio with 95%
confidence intervals from 2 2 tables. We used Bayes’ theorem
(posterior odds¼prior odds likelihood ratio) to estimate PPVs
(Knottnerus, 2002). The prior odds were derived from national
incidence rates stratified by age and sex for 2003, in which an
annual incidence of (for example) 5 per 1000 is the equivalent of
199 to 1 odds against having cancer diagnosed in the next year
(Cancer Research UK, 2003). This was repeated for those patients
with markers for iron deficiency.
As the number of cases was effectively predetermined, a power
calculation, rather than a sample size calculation, was performed.
For an estimated 5000 cases, there was 499% power to detect
5% having haemoglobin values in a particular band, compared
with 1% among controls. These estimates were derived from one
previous primary care study (Hamilton et al, 2005). Ethical
approval was obtained from London MREC.
RESULTS
Between 1 January 2000 and 31 July 2006, there were 6442 cases of
colorectal cancer (3421 men, 3021 women) recorded on the THIN
database; 45066 matched controls were available. Of these, 3183
(49%) cases and 10514 (23%) controls had a haemoglobin value
measured in the year before the index date. Cases’ haemoglobin
results were taken in a median (interquartile range) of 62 (28122)
days before the index date; equivalent figures for controls were 134
(59235) days. Details of the cases and controls are shown in
Table 1, and the haemoglobin results in Table 2.
Measurement of haemoglobin was more frequent in women;
6870 women (28.4%) had a haemoglobin result compared with
6827 men (25.0%); Po0.001, from a w
2 test. The positive likelihood
ratios for each level of haemoglobin were relatively constant across
the age bands.
An MCV result was available for 12599 (92%) and a ferritin was
recorded in 1548 (11%) of the 13697 with a haemoglobin result. In
cases, 764 (26%) of the 2951 MCV results showed microcytosis,
and 353 (49%) of the 723 ferritin results were low. In controls, 210
(2.2%) of the 9648 MCV results showed microcytosis, and 129
(16%) of the 825 ferritin results were low.
In a multivariable conditional logistic regression model, there
were strong (Po0.001) independent associations between color-
ectal cancer and anaemia, microcytosis, and a low ferritin; these
are shown in Figure 1. There was an antagonistic interaction
between microcytosis and low ferritin (interaction OR 0.25 (0.15,
0.43)).
Positive predictive values for anaemia alone (irrespective of
markers of iron deficiency) are shown for the two sexes in Tables 3
Table 1 Age and sex of cases and controls, in the whole cohort and in those with a haemoglobin estimation
In whole cohort With a haemoglobin estimation
Number of cases Number of controls Number of cases Number of controls
Age Total (%) Men (%) Total (%) Men (%) Total (%) Total (%)
30–59 1179 (18) 648 (55) 8254 (18) 4537 (55) 489 (41) 1158 (14)
60–69 1600 (25) 922 (58) 11204 (25) 6460 (58) 748 (47) 2215 (20)
70–79 2127 (33) 1180 (55) 14901 (33) 8272 (56) 1085 (51) 3823 (26)
80+ 1536 (24) 671 (44) 10707 (24) 4659 (44) 861 (56) 3318 (31)
Total 6442 (100) 3421 (53) 45066 (100) 23928 (53) 3183 (49) 10514 (23)
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sand 4. For the subgroup who had markers of iron deficiency,
results are shown in Tables 5 and 6.
Positive predictive value for current recommendations was
calculated for the those aged 460 years; men with markers of iron
deficiency and a haemoglobin o11.0gdl
 1 had a PPV of 13.3%
(CI 9.7, 18) and women with a haemoglobin o10.0gdl
 1 had 7.7%
(5.7, 11). To allow comparison with the one previous primary care
study, PPVs were calculated for two haemoglobin ranges, across all
ages and both sexes. For haemoglobin results below 9.9gdl
 1, the
PPV was 2.0% (CI 1.7, 2.3) and for 10.0–12.9gdl
 1, the PPV was
0.3% (0.2, 0.3).
DISCUSSION
This is the first study large enough to estimate the risk of colorectal
cancer across different ages, sexes, and levels of haemoglobin. It
confirms a strong association between anaemia and cancer, with
the risk rising as the haemoglobin falls; it also confirms iron
deficiency as an independent predictor of cancer. The results can
be used to guide individual doctors in deciding whether to refer
patients with an abnormal haemoglobin result; they can also be
used to improve current guidelines.
Strengths and weaknesses
The study is large, with haemoglobin results from 13757 primary
care patients, 3193 of whom were to be diagnosed with colorectal
cancer. Most of these results had been processed automatically,
reducing the chance of inputting errors. We could not confirm the
diagnoses of cancer, as histology results are not routinely logged
on GPs’ computer systems; nevertheless, it is unlikely that such a
serious diagnosis would be entered erroneously. Similarly, we
could not identify alternative causes for anaemia, microcytosis, or
a low ferritin.
A higher proportion of cases than controls had had their
haemoglobin measured. We accommodated this within our
calculation of PPVs, by using the national incidence figures for
our prior odds, using the following equation:
Posteriorodds ¼likelihoodratio priorodds
ðfromthenationalincidenceÞ
One possibility is that differential rates of haemoglobin estimation
made this calculation unreliable. The alternative was to study only
those patients in whom a blood result was available. The difficulty
with this approach is that the national incidence figures would not
then pertain, as the simple fact of requesting testing of the
haemoglobin selects a group in whom the risk of cancer is now
twice the national risk – in that something, probably symptoms,
triggered estimation of the haemoglobin.
Posteriorodds ¼LRof takingblood LRof particularresult
 prioroddsðnationalincidenceÞ
In this equation, the LR of taking blood was approximately 2, and the
LRs of particular result were approximately half the LRs we quote in
this paper. Thus, the effects cancel each other out. However, by
avoiding any bias from the different levels of testing between cases
and controls, we had to make another assumption, namely that all
untested patients had normal haemoglobin values. This is unlikely
to be true, with untested cases probably more likely to have
undiagnosed anaemia than untested controls. If so, our PPVs are
slight underestimates.
We also studied only one feature – anaemia. Some patients
might have had additional symptoms making a referral decision
easy (or, conversely, might have an alternative explanation for the
anaemia rendering referral unnecessary). It is likely that patients
with accompanying symptoms would have higher PPVs (and
conversely those with isolated anaemia have lower PPVs) than we
have calculated. This may be less important than it appears: a
common clinical problem in primary care (or any setting offering
care to unselected patients) is of an unexpected finding of anaemia
when colorectal cancer is not being considered, and the clinician
has to decide the likelihood of cancer. Furthermore, current
guidance uses only one variable; anaemia. To examine this
guidance critically, we have to use the same single variable.
Similarly, we studied only one diagnosis – colorectal cancer.
Investigation of anaemia may be appropriate for other diagnoses,
such as coeliac disease (Cannings-John et al, 2007). This is
incorporated into the BSG guidance. However, this does not
change the value of our figures with respect to cancer, and their
impact on cancer guidance.
The overall PPVs in this study are lower than those in the two
studies performed in the referred population (which identified
Table 2 Haemoglobin results in cases and controls, by sex
Men Women
Haemoglobin band
(gdl
 1)
Number (%) in
cases
Number (%) in
controls
Positive likelihood
ratio (CI)
Number (%) in
cases
Number (%) in
controls
Positive likelihood
ratio (CI)
o9.0 178 (5.2) 47 (0.2) 27 (19, 36) 221 (7.3) 36 (0.2) 43 (30, 61)
9.0–9.9 118 (3.5) 49 (0.2) 17 (12, 23) 146 (4.8) 85 (0.4) 12 (9.2, 16)
10.0–10.9 129 (3.8) 131 (0.6) 6.9 (5.4, 8.8) 226 (7.5) 225 (1.1) 7.0 (5.9, 8.4)
11.0–11.9 171 (5.0) 293 (1.2) 4.1 (3.4, 4.9) 238 (7.9) 616 (2.9) 2.7 (2.3, 3.1)
12.0–12.9 203 (5.9) 572 (2.4) 2.5 (2.1, 2.9) 289 (9.6) 1337 (6.3) 1.5 (1.3, 1.7)
412.9 805 (23.5) 4131 (17.3) 1.4 (1.3, 1.5) 459 (15.2) 2992 (14.2) 1.1 (0.98, 1.2)
Unmeasured 1817 (53.1) 18705 (78.2) 1442 (47.7) 15847 (75.0)
Total 3421 23928 3021 21138
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Figure 1 Semi-logarithmic plot of odds ratios for independent
associations of colorectal cancer with different haemoglobin values and
microcytosis and low ferritin results.
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scolorectal cancer in 6.3 and 7.4%) (Logan et al, 2002; James et al,
2005). However, they are similar to figures in one previous primary
care study of 0.97% for a haemoglobin 10.0–12.9gdl
 1 and 2.3%
for haemoglobin o10.0gdl
 1 in patients over 40 years (Hamilton
et al, 2005). This illustrates once again the higher risk in the
referred population compared to the primary care population as a
Table 6 PPV for colorectal cancer of haemoglobin result accompanied by indicators of iron deficiency, in women, by age, expressed as a percentage (with
95% CI)
Haemoglobin (gdl
 1)
Age (years)
Annual incidence
of colorectal cancer
in this age group (%)
(Cancer Research UK, 2003) o9.0 9.0–9.9 10.0–10.9 11.0–11.9 12.0–12.9 X13.0
30–59 0.02 0.6 (0.2, 2.2) 0.3 (0.1, 0.8) 0.6 (0.2, 2.1) 0.2 (0.1, 0.4) 0.1 (0.0, 0.3) 0.1 (0.0, 0.3)
60–69 0.11 45 (note) 3.5 (1.1, 11) 2.4 (1.0, 5.7) 1.5 (0.7, 3.3) 0.1 (0.0, 0.8) 2.9 (0.6, 12)
70–79 0.21 10 (5.2, 19) 8.6 (3.8, 18) 5.9 (3.0, 11) 2.1 (1.1, 4.0) 0.8 (0.4, 1.7) 0.4 (0.2, 1.1)
X80 0.27 10 (5.6, 17) 5.7 (3.0, 11) 2.5 (1.5, 4.1) 3.6 (2.0, 6.5) 1.5 (0.5, 4.2) 0.8 (0.3, 1.8)
Abbreviation: PPV¼positive predictive value. Note: in the red-shaded cell for age 60–69, with a haemoglobin value below 9gdl
 1, 36 cases but no controls had this
combination. Again, a likelihood ratio, and PPV, cannot be calculated when one cell is zero, but the PPV must be very high, so it has arbitrarily been set at 45%.
Table 5 PPV for colorectal cancer of haemoglobin result accompanied by indicators of iron deficiency, in men, by age, expressed as a percentage (with
95% CI)
Haemoglobin (gdl
 1)
Age (years)
Annual incidence
of colorectal cancer
in this age group (%)
(Cancer Research UK, 2003) o9.0 9.0–9.9 10.0–10.9 11.0–11.9 12.0–12.9 X13.0
60–69 0.19 45 (note) 12 (3.1, 37) 5.5 (1.2, 21) 6.5 (2.0, 19) 1.8 (0.7, 4.2) 1.4 (0.6, 3.6)
70–79 0.35 18 (8.7, 34) 16 (6.3, 35) 14 (5.9, 29) 4.1 (2.1, 8.0) 3.9 (1.8, 8.5) 1.7 (0.9, 3.1)
X80 0.43 15 (7.3, 28) 31 (5.6, 77) 8.2 (3.7, 17) 4.0 (1.6, 9.3) 1.5 (0.5, 4.2) 1.4 (0.6, 3.1)
Abbreviation: PPV¼positive predictive value. Note: for the age band 30–59, 64 cases, but only 11 controls, had markers of iron deficiency, making meaningful analysis
impossible. In the red-shaded cell for age 60–69, with a haemoglobin value below 9gdl
 1, 30 cases but no controls had this combination. Again, a likelihood ratio, and PPV,
cannot be calculated when one cell is zero, but the PPV must be very high, so it has arbitrarily been set at 45%.
Table 4 PPV for colorectal cancer of haemoglobin result taken in primary care, in women, by age, expressed as a percentage (with 95% CI)
Haemoglobin (gdl
 1)
Age (years)
Annual incidence
of colorectal cancer
in this age group (%)
(Cancer Research UK, 2003) o9.0 9.0–9.9 10.0–10.9 11.0–11.9 12.0–12.9 X13.0
30–59 0.02 0.9 (0.3, 2.9) 0.3 (0.1, 0.6) 0.4 (0.2, 0.8) 0.1 (0.1, 0.2) 0.0 (0.0, 0.1) 0.0 (0.0, 0.0)
60–69 0.11 45 (note) 2.7 (1.2, 5.9) 1.2 (0.7, 2.0) 0.4 (0.3, 0.6) 0.2 (0.1, 0.2) 0.1 (0.1, 0.2)
70–79 0.21 8.6 (5.4, 14) 3.6 (2.1, 6.0) 1.9 (1.4, 2.6) 0.5 (0.4, 0.6) 0.3 (0.3, 0.4) 0.2 (0.2, 0.2)
X80 0.27 7.1 (4.5, 11) 2.2 (1.5, 3.1) 1.2 (0.9, 1.5) 0.6 (0.5, 0.8) 0.3 (0.2, 0.4) 0.2 (0.2, 0.3)
Abbreviation: PPV¼positive predictive value. Note: in the red-shaded cells for age bands 60–69, with a haemoglobin value below 9gdl
 1, 41 cases but no controls, had this
combination. Strictly, a likelihood ratio, and PPV, cannot be calculated when one cell is zero, but the PPV must be very high, so it has arbitrarily been set at 45%.
Table 3 PPV for colorectal cancer of haemoglobin result taken in primary care, in men, by age, expressed as a percentage (with 95% CI)
Haemoglobin (gdl
 1)
Age (years)
Annual incidence
of colorectal cancer
in this age group (%)
(Cancer Research UK, 2003) o9.0 9.0–9.9 10.0–10.9 11.0–11.9 12.0–12.9 X13.0
30–59 0.026 1.3 (0.4, 4.3) 1.4 (0.2, 10) 0.8 (0.3, 2.2) 0.8 (0.2, 2.9) 0.2 (0.1, 0.3) 0.1 (0.1, 0.1)
60–69 0.19 7.6 (3.4, 16) 7.2 (2.9, 17) 2.3 (1.1, 4.8) 1.4 (0.9, 2.3) 0.7 (0.5, 1.0) 0.3 (0.3, 0.3)
70–79 0.35 8.8 (5.4, 14) 4.0 (2.5, 6.3) 3.2 (2.2, 4.8) 1.5 (1.2, 2.0) 1.0 (0.7, 1.2) 0.4 (0.3, 0.4)
X80 0.43 6.8 (4.2, 11) 6.0 (3.4, 10) 1.6 (1.1, 2.2) 1.0 (0.8, 1.4) 0.6 (0.5, 0.8) 0.4 (0.3, 0.5)
Abbreviation: PPV¼positive predictive value.
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swhole, emphasising the need to use primary care data to guide
primary care decisions (Hamilton and Sharp, 2004).
Comparison with current guidance
One major problem with current guidance is that no threshold
figure has been published for the risk of cancer warranting urgent
investigation. Patients, doctors, and commissioners will each have
a viewpoint on this. The current cancer detection rate in UK rapid
investigation clinics is 6–11%; however, these clinics identify only
around a third of colorectal cancers (Rai and Kelly, 2007). This
reflects an important but awkward fact – less than half of the
patients with colorectal cancer have a high-risk symptom, such as
rectal bleeding, with its PPV for cancer being 2.4–5.7% (Ellis and
Thompson, 2005; Hamilton et al, 2005; du Toit et al, 2006). The
majority have softer symptoms, such as abdominal pain,
constipation, or diarrhoea, each with risks of cancer of around
1% (Hamilton et al, 2005). If a higher proportion of symptomatic
cancers is to be detected through rapid investigation clinics, then a
lower threshold risk – perhaps as low as 2% – has to be accepted.
We consider most patients would wish to have urgent investigation
with a risk of this magnitude. This is tacitly accepted by current
guidance, in which referral for persistent diarrhoea is advised, even
though the risk of cancer after two primary care attendances with
diarrhoea is still quite low, at around 1.5% (Hamilton et al, 2005).
The current recommendations for anaemia (which require the
presence of iron deficiency as well as anaemia) had PPVs of 13.3%
for men and 7.7% for women. This clear sex difference remained
for haemoglobin values above the current referral threshold.
Positive predictive values in men were above 4% for all
haemoglobin values up to 12.0gdl
 1, whereas women’s PPVs
were generally lower. This reflects the higher overall incidence of
colorectal cancer in men, together with the lower mean
haemoglobin in all ages of women, not just in those who are
premenopausal (Guralnik et al, 2004). Nonetheless, it can be
argued that in patients with iron deficiency, any degree of anaemia
up to 12gdl
 1 warrants urgent investigation (as the BSG guidance
suggests, albeit without stating urgent investigation is warranted).
Simpler guidance would be to ignore features of iron deficiency
entirely and recommend urgent referral of patients over 60 with
unexplained anaemia on the haemoglobin value alone. If this were
done, the current threshold figures of 11gdl
 1 for men and
10gdl
 1 for women appear reasonable, with almost all PPVs above
2%, and most well above this figure.
This study provides an evidence base for investigation of
anaemia detected in primary care. As always, there is a trade-off
between identifying as many cancers as possible (sensitivity) and
keeping the number of false-positives reasonable (specificity).
Colorectal cancer generally presents with low-risk symptoms, so if
earlier symptomatic diagnosis is to be achieved, lower specificity
cannot be avoided. The current recommendations will miss some
cancers, as the threshold haemoglobin figures are low. We
recommend that the requirement for iron deficiency is removed
from current guidance, while the same threshold levels of
haemoglobin are retained.
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